Maglasang, John Prince H.
HRN: 25-61-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/02/2024
08/09/2024
IV
2.25g
Q12hrs
Ards Sec To Severe Dengue
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes